Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Biomarkers can reveal IBS

08.05.2012
Irritable bowel syndrome (IBS) is hard to diagnose as well as treat, but researchers at the Sahlgrenska Academy, at the University of Gothenburg, Sweden, have discovered a way of confirming the disorder using stool samples.
Irritable bowel syndrome (IBS) causes chronic or recurring problems with pain and discomfort in the abdomen together with changes in bowel habits. The syndrome is common and is believed to be linked to dysfunction of the stomach and intestines, but our understanding of IBS is incomplete, making it difficult to diagnose and treat.

Identified specific proteins
Researchers at the Sahlgrenska Academy have now identified specific proteins that can be used to identify patients with IBS:
“The proteins we’ve been investigating, granins, are found in various forms with different functions in the nervous, immune and digestive systems,” explains researcher Lena Öhman. “Our studies show that IBS patients have higher levels of some granins and lower levels of others in their faeces.”

Hope for new treatments
Further studies are needed, but if granins can be used to diagnose IBS, it is hoped that this will contribute to the development of new treatments.
The study, which compared 82 IBS patients with 29 healthy subjects, was published in the American Journal of Gastroenterology.

About the study:
Granins (chromogranin A) have previously been shown to serve as biomarkers for other inflammatory diseases in the gut, such as ulcerous colitis and Crohn’s disease. The present study looked at the variants secretogranin II and chromogranin B and found that IBS patients have high levels of the former and low levels of the latter.
Irritable bowel syndrome (IBS):
IBS affects an estimated 10-20% of the population and causes chronic or recurring problems with pain and/or discomfort in the abdomen, together with changes in bowel habits. The causes are largely unknown, but disturbances of the gut flora and a change in the pattern of the gut’s immune defence have been mooted as possible factors behind the symptoms. There is currently no cure for IBS, but in many cases the symptoms can be alleviated.

Bibliographic data
Journal: Am J Gastroenterol 2012; 107:440–447; doi:10.1038/ajg.2011.458; published online 10 January 2012
Title: Altered Levels of Fecal Chromogranins and Secretogranins in IBS: Relevance for Pathophysiology and Symptoms?
Authors: Lena Öhman PhD1,2, Mats Stridsberg MD, PhD3, Stefan Isaksson MSc1,2, Pernilla Jerlstad BSc1 and Magnus Simrén MD, PhD1

For more information, please contact: Lena Öhman
Telephone: +46 (0)31 786 6214
E-mail: lena.ohman @microbio.gu.se

Helena Aaberg | idw
Further information:
http://bit.ly/zuS3Ll
http://www.gu.se

More articles from Health and Medicine:

nachricht Spanish scientists create a 3-D bioprinter to print human skin
24.01.2017 | Carlos III University of Madrid

nachricht Tracking movement of immune cells identifies key first steps in inflammatory arthritis
23.01.2017 | Massachusetts General Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists spin artificial silk from whey protein

X-ray study throws light on key process for production

A Swedish-German team of researchers has cleared up a key process for the artificial production of silk. With the help of the intense X-rays from DESY's...

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Breaking the optical bandwidth record of stable pulsed lasers

24.01.2017 | Physics and Astronomy

Choreographing the microRNA-target dance

24.01.2017 | Life Sciences

Spanish scientists create a 3-D bioprinter to print human skin

24.01.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>